# Metagenomi Therapeutics, Inc.: Form S-1, filed Jan 5, 2024

- Company: [Metagenomi Therapeutics, Inc.](/companies/mgx.md) (CIK 1785279)
- Form: S-1
- Filed: 2024-01-05
- Accepted by EDGAR: Jan 5, 2024, 17:16 ET
- Period: not reported
- Accession: 0001193125-24-003477
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1785279/000119312524003477/d425213ds1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785279/000119312524003477/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785279/000119312524003477/d425213ds1.htm

Filed Jan 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-003477. Last ingested by Listed: Nov 11, 2026, 00:33 ET. No prices; not investment advice.